Statements
- This Is Bayer
- Agriculture
- Consumer Health
- Pharmaceuticals
- Products
- Community
- News & Stories
- Careers
- This Is Bayer
- Agriculture
- Consumer Health
- Pharmaceuticals
- Products
- Community
- News & Stories
- Careers
Statement on RoundUp Active Ingredient Safety
American Agriculture at Risk- An Open Letter on Glyphosate
Bayer Statement on the National Association of Black Farmers’ Proposed Legal Filing
Standing Up to Racism and Injustice
Important Update About COVID-19
Bayer statement on Monsanto/glyphosate trial
Bayer Awards $1.2 Million in Grants press release
Roundup Ready PLUS Program press release
DEKALB 2018 NCGA National Yield Winner press release
Bayer statement on Xarelto March 25, 2019
Kogenate FS Recall Healthcare Provider Notification
Kogenate FS Recall Bayer Response to NHF/HFA
Breakfast Beyond the Bell Event photo
“Bayer is pleased with the Delaware Supreme Court’s decision to affirm the Chancery Court’s dismissal with prejudice of Merck’s meritless case against the company. The Supreme Court’s affirmance is based on the same reasons given by the Chancery Court, which found that Merck was solely liable and responsible for all product-liability claims relating to the time before the closing of the Purchase Agreement between the two companies under its terms.”